Atrial Fibrillation News and Research

RSS
Atrial fibrillation (AF) is the most common arrhythmia. An arrhythmia is a problem with the speed or rhythm of the heartbeat. A disorder in the heart’s electrical system causes AF and other types of arrhythmia. AF occurs when rapid, disorganized electrical signals in the heart’s two upper chambers, called the atria, cause them to contract very fast and irregularly (this is called fibrillation). As a result, blood pools in the atria and isn’t pumped completely into the heart’s two lower chambers, called the ventricles. When this happens, the heart’s upper and lower chambers don’t work together as they should. Often, people who have AF may not even feel symptoms. However, even when not noticed, AF can lead to an increased risk of stroke. In many patients, particularly when the rhythm is extremely rapid, AF can cause chest pain, heart attack, or heart failure. AF may occur rarely or every now and then, or it may become a persistent or permanent heart rhythm lasting for years.
FDA approves St. Jude Medical's MultiSteering Technology software for optimizing neurostimulation therapy

FDA approves St. Jude Medical's MultiSteering Technology software for optimizing neurostimulation therapy

nContact Surgical initiates clinical trials of its convergent procedure for paroxysmal AF

nContact Surgical initiates clinical trials of its convergent procedure for paroxysmal AF

Boehringer Ingelheim to announce positive results from its RE-COVER study

Boehringer Ingelheim to announce positive results from its RE-COVER study

New preventive screening packages for heart disease

New preventive screening packages for heart disease

MHI performs its first Amptlazer- Cardiac Plug implant

MHI performs its first Amptlazer- Cardiac Plug implant

MHI team performs catheter implantation of the new Amptlazer Cardiac Plug prosthesis

MHI team performs catheter implantation of the new Amptlazer Cardiac Plug prosthesis

Biotel reports net earnings of $128,000 for its first quarter ended September 30, 2009

Biotel reports net earnings of $128,000 for its first quarter ended September 30, 2009

Positive short term results from combined surgical and electrophysiological approach to treat AF

Positive short term results from combined surgical and electrophysiological approach to treat AF

Joint project focuses on finding ways to prevent dementia, including Alzheimer's disease

Joint project focuses on finding ways to prevent dementia, including Alzheimer's disease

St. Jude Medical announces implantation of the first patient in China with its Eon rechargeable neurostimulator

St. Jude Medical announces implantation of the first patient in China with its Eon rechargeable neurostimulator

Review of the results of Phase 2b clinical trial on PASCAL announced

Review of the results of Phase 2b clinical trial on PASCAL announced

deCODE genetics files voluntary petition for relief under Chapter 11 of the United States Bankruptcy Code

deCODE genetics files voluntary petition for relief under Chapter 11 of the United States Bankruptcy Code

Genetic test for familial Dilated Cardiomyopathy launched by PGxHealth

Genetic test for familial Dilated Cardiomyopathy launched by PGxHealth

RecordAF presents results of recently diagnosed and treated patients with atrial fibrillation

RecordAF presents results of recently diagnosed and treated patients with atrial fibrillation

Merck to market and develop cardiovascular medicines for a range of cardiovascular disorders

Merck to market and develop cardiovascular medicines for a range of cardiovascular disorders

ARYx Therapeutics announces operating results for the third quarter of 2009

ARYx Therapeutics announces operating results for the third quarter of 2009

New mapping technology to treat patients with heart rhythm disorders

New mapping technology to treat patients with heart rhythm disorders

IntriCon to launch new CDM device at 2009 AHA Scientific Sessions

IntriCon to launch new CDM device at 2009 AHA Scientific Sessions

Cardiome Pharma announces financial results for the three months ended September 30, 2009

Cardiome Pharma announces financial results for the three months ended September 30, 2009

Scientists identify a novel cellular source of atrial fibrillation

Scientists identify a novel cellular source of atrial fibrillation

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.